{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:56:17Z","timestamp":1794916577076,"version":"4.9.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00105-023-05229-z","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T09:01:38Z","timestamp":1697619698000},"page":"858-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Praktikabilit\u00e4t der Leitlinie zu\u00a0Haut- und Weichgewebeinfektionen","Practicability of the German guidelines on skin and soft tissue infections"],"prefix":"10.1007","volume":"74","author":[{"given":"Cord","family":"Sunderk\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Michl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"5229_CR1","unstructured":"FDA (2013) Guidance for industry acute bacterial skin and skin structure infections: developing drugs for treatment. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm071185.pdf. Zugegriffen: 20.\u00a0Juli 2023"},{"key":"5229_CR2","first-page":"Doc20","volume":"8","author":"KF Bodmann","year":"2020","unstructured":"Bodmann\u00a0KF, Grabein\u00a0B, Kresken\u00a0M (2020) S2k guideline \u201ccalculated parenteral initial treatment of bacterial infections in adults\u2014update 2018\u201d, 2nd updated version: foreword. GMS Infect Dis 8:Doc20","journal-title":"GMS Infect Dis"},{"key":"5229_CR3","first-page":"1417","volume":"18","author":"C Drerup","year":"2020","unstructured":"Drerup\u00a0C, Eveslage\u00a0M, Sunderkoetter\u00a0C et\u00a0al (2020) Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis. J\u00a0Dtsch Dermatol Ges 18:1417\u20131424","journal-title":"J Dtsch Dermatol Ges"},{"key":"5229_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000494691","volume":"14","author":"G Exarchos","year":"2019","unstructured":"Exarchos\u00a0G, Metaxa\u00a0L, Constantinidou\u00a0A et\u00a0al (2019) Delayed breast cellulitis following surgery for breast cancer: a\u00a0literature review. Breast Care (Basel) 14:48\u201352","journal-title":"Breast Care (Basel)"},{"key":"5229_CR5","doi-asserted-by":"publisher","first-page":"ojad050","DOI":"10.1093\/asjof\/ojad050","volume":"5","author":"A Gabriel","year":"2023","unstructured":"Gabriel\u00a0A, Chan\u00a0V, Caldarella\u00a0M et\u00a0al (2023) Cellulite: current understanding and treatment. Aesthet Surg J Open Forum 5:ojad50","journal-title":"Aesthet Surg J Open Forum"},{"key":"5229_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.4065\/71.6.552","volume":"71","author":"CL Loprinzi","year":"1996","unstructured":"Loprinzi\u00a0CL, Okuno\u00a0S, Pisansky\u00a0TM et\u00a0al (1996) Postsurgical changes of the breast that mimic inflammatory breast carcinoma. Mayo Clin Proc 71:552\u2013555","journal-title":"Mayo Clin Proc"},{"key":"5229_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1365-2222.2001.00992.x","volume":"31","author":"A Novalbos","year":"2001","unstructured":"Novalbos\u00a0A, Sastre\u00a0J, Cuesta\u00a0J et al (2001) Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy 31:438\u2013443","journal-title":"Clin Exp Allergy"},{"key":"5229_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1054\/brst.2002.0470","volume":"11","author":"F Peters","year":"2002","unstructured":"Peters\u00a0F, Petersen\u00a0EE, Kirkpatrick\u00a0CJ (2002) Isolated erythema (cellulitis) of the breast. Breast 11:484\u2013488","journal-title":"Breast"},{"key":"5229_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jaci.2015.03.012","volume":"136","author":"A Romano","year":"2015","unstructured":"Romano\u00a0A, Gaeta\u00a0F, Valluzzi\u00a0RL et al (2015) IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J\u00a0Allergy Clin Immunol 136:685\u2013691","journal-title":"J Allergy Clin Immunol"},{"key":"5229_CR10","doi-asserted-by":"crossref","unstructured":"Smith E, Patel M, Thomas K (2017) Which outcomes are reported in cellulitis trials? Results of a\u00a0review of outcomes included in cellulitis trials and a\u00a0patient priority setting survey. Br J Dermatol 178:1028\u20131034","DOI":"10.1111\/bjd.16235"},{"key":"5229_CR11","doi-asserted-by":"publisher","first-page":"e210021","DOI":"10.1001\/jamasurg.2021.0021","volume":"156","author":"B Sousa-Pinto","year":"2021","unstructured":"Sousa-Pinto\u00a0B, Blumenthal\u00a0KG, Courtney\u00a0L et al (2021) Assessment of the frequency of dual allergy to penicillins and cefazolin: a\u00a0systematic review and meta-analysis. JAMA Surg 156:e210021","journal-title":"JAMA Surg"},{"key":"5229_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/bjd.16494","volume":"178","author":"C Sunderkotter","year":"2018","unstructured":"Sunderkotter\u00a0C (2018) Cellulitis: what to measure, how to define? Systematic review of outcomes from cellulitis trials. Br J Dermatol 178:1000\u20131001","journal-title":"Br J Dermatol"},{"key":"5229_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5414\/ALX02314E","volume":"6","author":"C Sunderkotter","year":"2022","unstructured":"Sunderkotter\u00a0C (2022) Suspected allergy to beta-Lactam antibiotics: an infectiological perspective. Allergol Select 6:27\u201332","journal-title":"Allergol Select"},{"key":"5229_CR14","first-page":"501","volume":"13","author":"C Sunderk\u00f6tter","year":"2015","unstructured":"Sunderk\u00f6tter\u00a0C, Becker\u00a0K (2015) Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J\u00a0Dtsch Dermatol Ges 13:501\u2013524 (quiz 525\u2013506)","journal-title":"J Dtsch Dermatol Ges"},{"key":"5229_CR15","first-page":"Doc11","volume":"8","author":"C Sunderkotter","year":"2020","unstructured":"Sunderkotter\u00a0C, Becker\u00a0K, Eckmann\u00a0C et\u00a0al (2020) Calculated initial parenteral treatment of bacterial infections: skin and soft tissue infections. GMS Infect Dis 8:Doc11","journal-title":"GMS Infect Dis"},{"key":"5229_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/ddg.13790_g","volume":"17","author":"C Sunderkotter","year":"2019","unstructured":"Sunderkotter\u00a0C, Becker\u00a0K, Eckmann\u00a0C et al (2019) S2k-Leitlinie Haut- und Weichgewebeinfektionen Auszug aus \u201eKalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen\u2013Update 2018\u201c. J\u00a0Dtsch Dermatol Ges 17:345\u2013371","journal-title":"J Dtsch Dermatol Ges"},{"key":"5229_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/ddg.13790","volume":"17","author":"C Sunderkotter","year":"2019","unstructured":"Sunderkotter\u00a0C, Becker\u00a0K, Eckmann\u00a0C et\u00a0al (2019) S2k guidelines for skin and soft tissue infections. Excerpts from the S2k guidelines for \u201ccalculated initial parenteral treatment of bacterial infections in adults\u2014update 2018\u201d. J\u00a0Dtsch Dermatol Ges 17:345\u2013369","journal-title":"J Dtsch Dermatol Ges"},{"key":"5229_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5414\/ALX02104E","volume":"4","author":"G Wurpts","year":"2020","unstructured":"Wurpts\u00a0G, Aberer\u00a0W, Dickel\u00a0H et al (2020) Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics: guideline of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Society of Allergology (AeDA), German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Austrian Society for Allergology and Immunology (OGAI), and the Paul-Ehrlich Society for Chemotherapy (PEG). Allergol Select 4:11\u201343","journal-title":"Allergol Select"},{"key":"5229_CR19","first-page":"1041","volume":"20","author":"M Zidane","year":"2022","unstructured":"Zidane\u00a0M, Jungkunz\u00a0HW, Kahle\u00a0B et\u00a0al (2022) S1 guideline: differential diagnosis of acute and chronic redness of the lower legs. J\u00a0Dtsch Dermatol Ges 20:1041\u20131047","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05229-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05229-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05229-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T14:03:12Z","timestamp":1698156192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05229-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["5229"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05229-z","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"4 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Sunderk\u00f6tter und C.\u00a0Michl geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}